Cancer-specific survival | Categories | p | HR | 95% CI |
---|---|---|---|---|
AR/FOXA1/CK14 status | AR+ FOXA1+ CK14– versus AR+ FOXA1–CK14+ | 0.033 | 0.26 | 0.07–0.89 |
Pathologic tumor size | pT ≥ 20 mm versus < 20 mm | 0.026 | 2.15 | 1.10–4.19 |
Pathologic nodal stage | pN+ versus pN0–pNX | 0.017 | 2.28 | 1.16–4.46 |